ReCode Therapeutics website screenshot

ReCode Therapeutics

ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California with operations in Dallas, Texas, founded in 2015 out of research at UT Southwestern. Its Selective Organ Targeting (SORT) lipid nanoparticle platform is a delivery technology that directs mRNA and gene-correction payloads to organs, tissues and cells beyond the liver — the constraint that has limited genetic medicines to date — with redosing capability. Its lead programmes are RCT1100, an inhaled DNAI1 mRNA therapy for primary ciliary dyskinesia which has reported first-ever proof of activity in PCD patients, and RCT2100, an inhaled CFTR mRNA therapy for cystic fibrosis now in a Phase 2 combination trial with ivacaftor; both hold U.S. FDA Orphan Drug designation. The company collaborates with Intellia Therapeutics on CRISPR-based gene correction for cystic fibrosis, is funded in part by the Cystic Fibrosis Foundation, and has raised over $260 million in Series B financing. ReCode Therapeutics runs no developer program and publishes no product API, developer portal or API documentation; the only machine-readable surface reachable without credentials is the WordPress REST content API behind recodetx.com, catalogued here alongside the llms.txt the site publishes.

ReCode Therapeutics publishes 1 API on the APIs.io network. Tagged areas include Company, Genetic Medicine, Biotechnology, Biopharmaceutical, and mRNA.

The ReCode Therapeutics catalog on APIs.io includes 1 JSON-LD context.

ReCode Therapeutics’ developer surface includes product news, authentication, and 31 more developer resources.

19.2/100 emerging ▬ flat Agent 4/100 human only Front door AI 1/6 silent saas Full breakdown ↓
scored 2026-09-25 · rubric v0.23.0
AccessOpen
1 APIs
CompanyGenetic MedicineBiotechnologyBiopharmaceuticalmRNAgene-correctionLipid NanoparticlesDrug DeliveryRare DiseaseCystic Fibrosisprimary-ciliary-dyskinesiaClinical TrialsLife Sciencescontent-api

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-25 · rubric v0.23.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/recode-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

APIs 1

Individual APIs this provider publishes, each with its own machine-readable definition.

ReCode Therapeutics Website (WordPress REST)

The public WordPress REST API (wp-json) of the ReCode Therapeutics website at recodetx.com: the route index of the site's content management system, catalogued as one site surfa...

Open Collections 1

Open, tool-agnostic API collections (OpenAPI-derived and Bruno).

API Collection

OPEN COLLECTION

Semantic Vocabularies 1

JSON-LD contexts and semantic vocabularies used across these APIs.

Recode Therapeutics Organization Context

0 classes · 0 properties

JSON-LD

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Recode Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 3

MCP servers, agent skills, and machine-readable catalogs

Design & Contract 6

Pagination, idempotency, versioning, errors, and events

Build 2

SDKs, sample code, and the tooling you integrate with

Access & Security 2

Authentication, authorization, and security posture

Commercial 2

Pricing, plans, and the legal terms of use

Company 9

The organization behind the API

Scroll for all 9

Other 9

Properties that don't map to a standard resource type

Scroll for all 9

Source (apis.yml)

apis.yml Raw ↑
aid: recode-therapeutics
name: ReCode Therapeutics
description: ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California with
  operations in Dallas, Texas, founded in 2015 out of research at UT Southwestern. Its Selective Organ Targeting (SORT) lipid
  nanoparticle platform is a delivery technology that directs mRNA and gene-correction payloads to organs, tissues and cells
  beyond the liver — the constraint that has limited genetic medicines to date — with redosing capability. Its lead programmes
  are RCT1100, an inhaled DNAI1 mRNA therapy for primary ciliary dyskinesia which has reported first-ever proof of activity
  in PCD patients, and RCT2100, an inhaled CFTR mRNA therapy for cystic fibrosis now in a Phase 2 combination trial with ivacaftor;
  both hold U.S. FDA Orphan Drug designation. The company collaborates with Intellia Therapeutics on CRISPR-based gene correction
  for cystic fibrosis, is funded in part by the Cystic Fibrosis Foundation, and has raised over $260 million in Series B financing.
  ReCode Therapeutics runs no developer program and publishes no product API, developer portal or API documentation; the only
  machine-readable surface reachable without credentials is the WordPress REST content API behind recodetx.com, catalogued
  here alongside the llms.txt the site publishes.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: true
  label: Hosted service · you call their endpoint
  confidence: high
  source:
  - openapi
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: open
  trial: false
  try_now: false
  public: true
  label: Open access
  confidence: low
  source:
  - authentication
  - security
  generated: '2026-09-02'
  method: derived
image: https://recodetx.com/wp-content/uploads/2022/06/ReCode_Logo_Primary_Web.svg
url: https://raw.githubusercontent.com/api-evangelist/recode-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.23'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Genetic Medicine
- Biotechnology
- Biopharmaceutical
- mRNA
- gene-correction
- Lipid Nanoparticles
- Drug Delivery
- Rare Disease
- Cystic Fibrosis
- primary-ciliary-dyskinesia
- Clinical Trials
- Life Sciences
- content-api
tags_raw:
- Company
- genetic-medicines
- biotechnology
- biopharmaceuticals
- mrna
- gene-correction
- lipid-nanoparticles
- drug-delivery
- rare-disease
- cystic-fibrosis
- primary-ciliary-dyskinesia
- clinical-trials
- life-sciences
- content-api
apis:
- aid: recode-therapeutics:recodetx-com-website-wordpress-rest
  name: ReCode Therapeutics Website (WordPress REST)
  description: 'The public WordPress REST API (wp-json) of the ReCode Therapeutics website at recodetx.com: the route index
    of the site''s content management system, catalogued as one site surface rather than as separate APIs.'
  baseURL: https://recodetx.com/wp-json
  tags:
  - WordPress
  x-surface: platform-generated
  properties:
  - type: Documentation
    url: https://recodetx.com/wp-json
  x-platform: wordpress
  x-platform-surface: rest
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Overlay
  url: overlays/recode-therapeutics-content-overlay.yaml
- type: DomainSecurity
  url: security/recode-therapeutics-domain-security.yml
- type: Website
  url: https://recodetx.com/
- type: About
  url: https://recodetx.com/about/
- type: Science
  url: https://recodetx.com/science/
- type: Pipeline
  url: https://recodetx.com/pipeline/
- type: ClinicalStudies
  url: https://recodetx.com/clinical-studies/
- type: Patients
  url: https://recodetx.com/patients/
- type: Partnering
  url: https://recodetx.com/partnering/
- type: Leadership
  url: https://recodetx.com/leadership/
- type: Careers
  url: https://recodetx.com/careers-culture/
- type: News
  url: https://recodetx.com/news/
- type: BlogRSS
  url: https://recodetx.com/feed/
- type: Events
  url: https://recodetx.com/events/
- type: MediaLibrary
  url: https://recodetx.com/media-library/
- type: TermsOfService
  url: https://recodetx.com/terms-conditions/
- type: PrivacyPolicy
  url: https://recodetx.com/privacy-policy/
- type: CookiePolicy
  url: https://recodetx.com/cookie-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/recode-therapeutics/
- type: Twitter
  url: https://twitter.com/ReCodeTx
- type: Instagram
  url: https://www.instagram.com/recodetx/
- type: Sitemap
  url: https://recodetx.com/sitemap.xml
- type: SecondaryMarket
  url: https://forgeglobal.com/recode-therapeutics_stock/
- type: LLMsTxt
  url: llms/recode-therapeutics-llms.txt
- type: WellKnown
  url: well-known/recode-therapeutics-well-known.yml
- type: Authentication
  url: authentication/recode-therapeutics-authentication.yml
- type: Conventions
  url: conventions/recode-therapeutics-conventions.yml
- type: Conformance
  url: conformance/recode-therapeutics-conformance.yml
- type: ErrorCatalog
  url: errors/recode-therapeutics-problem-types.yml
- type: Lifecycle
  url: lifecycle/recode-therapeutics-lifecycle.yml
- type: DataModel
  url: data-model/recode-therapeutics-data-model.yml
- type: JSONLD
  url: json-ld/recode-therapeutics-json-ld.yml
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-05'
  status: enriched
  artifacts_added: 17
  pass: local-v1

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/recode-therapeutics"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/recode-therapeutics/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/recode-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.